Assignee
TRANSPOSAGEN BIOPHARMACEUTICALS INC
US·0 granted patents·7 pending applications·0 citations·filing 2013–2016
Top patents by PatentIndex Score
7 records- 0160US2016302397A1Genetically modified rat models for severe combined immunodeficiency (scid)TRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0256US2015052624A1Genetically modified rat models for painTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0355US2015052623A1Genetically modified rat models for pharmacokineticsTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0455US2016174533A1Genetically modified rat models for drug metabolismTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0553US2016174534A1Genetically modified rat models for pharmacokineticsTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0653US2016174532A1Genetically modified rat models for painTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0749US2014041063A1Genetically Modified Rat Models for Obesity and DiabetesTRANSPOSAGEN BIOPHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TRANSPOSAGEN BIOPHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →